It inhibits inflammation by binding HMGB1, suppresses proliferation and dedifferentiation of CSCs, and DNA damage via the HMGB1/TLR4/NF-κB pathway, suggesting its potential as a CRC preventive agent [73]. The gene discussed is TLR4; the disease is colorectal carcinoma.